📰 Si Bone News
Page 7 - Si Bone News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Si Bone. Real-time updates on events, politics, business and more.
May 29, 2022
SI-BONE (NASDAQ:SIBN – Get Rating) and Embecta (NASDAQ:EMBC – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk. Profitability This table compares SI-BONE and Embecta’s net margins, return on […]
May 24, 2022
Shares of SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) have been assigned a consensus recommendation of “Buy” from the ten ratings firms that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating and eight have issued a buy rating on the company. The average 12 month target price among […]
April 22, 2022
Wall Street brokerages forecast that SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) will report sales of $22.37 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for SI-BONE’s earnings. The highest sales estimate is $22.40 million and the lowest is $22.34 million. SI-BONE posted sales of $20.44 million during the […]
April 20, 2022
SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) insider Anthony J. Recupero sold 577 shares of the business’s stock in a transaction on Monday, April 18th. The stock was sold at an average price of $19.92, for a total value of $11,493.84. Following the completion of the transaction, the insider now directly owns 179,545 shares of the […]
April 12, 2022
SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) has been assigned an average recommendation of “Buy” from the ten brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 year price target among brokers that […]
March 26, 2022
Zacks Investment Research upgraded shares of SI-BONE (NASDAQ:SIBN – Get Rating) from a sell rating to a hold rating in a research report sent to investors on Friday, Zacks.com reports. According to Zacks, “SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint […]
March 25, 2022
Private Ocean LLC reduced its position in SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) by 35.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,156 shares of the company’s stock after selling 1,170 shares during the period. Private Ocean LLC’s holdings in […]
January 10, 2022
Item 2.02 - Results of Operations and Financial Condition. -------------------------------------------------------------------------------- On January 10, 2022, SI-BONE, Inc. issued a press release... | January 10, 2022
November 5, 2019
Chief executive in the united states will be held accountable by the other two branches. donald trump is saying, no, i bone. th wont. this is a dangerous moment happening in real time. >> and maya wiley, this is why the integrity of the court is so critical. that before were at the end of whatever this is going to be, the court may get a slice of this, the court may get a cut at this baseball and theyve got to proceed with their integrity in tact. >> theyve got to proceed with their integrity in...